• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺转运体成像正常的患者中持续性药物性帕金森综合征

Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging.

作者信息

Hong Jin Yong, Sunwoo Mun Kyung, Oh Jungsu S, Kim Jae Seung, Sohn Young H, Lee Phil Hyu

机构信息

Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea.

Department of Neurology, Bundang Jesaeng General Hospital, Seongnam, Korea.

出版信息

PLoS One. 2016 Jun 13;11(6):e0157410. doi: 10.1371/journal.pone.0157410. eCollection 2016.

DOI:10.1371/journal.pone.0157410
PMID:27294367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4905632/
Abstract

Functional neuroimaging for the dopamine transporter (DAT) is used to distinguish drug-induced parkinsonism (DIP) from subclinical Parkinson's disease (PD). Although DIP patients who show a normal DAT image are expected to recover completely, some do not. We investigated whether these patients showed changes in striatal DAT activity using semi-quantitative analysis of 18F-FP-CIT PET data. DIP patients with visually normal DAT images were selected from medical records. The subjects were classified as patients who recovered partially (PR) or completely within 12 months (CR). The 18F-FP-CIT uptake in each striatal subregion was compared between the CR and the PR groups. In total, 41 and 9 patients of the CR and PR groups were assessed, respectively. The two patient groups were comparable in terms of clinical characteristics including age, sex, and severity of parkinsonism. From semi-quantitative analysis of the PET image, the PR patients showed a relatively lower ligand uptake in the ventral striatum, the anterior putamen and the posterior putamen compared with the CR patients. This result suggests that persistent DIP in patients with visually normal DAT imaging may be associated with subtle decrement of DAT activity.

摘要

用于多巴胺转运体(DAT)的功能神经成像可用于区分药物性帕金森综合征(DIP)和亚临床帕金森病(PD)。尽管预计DAT图像正常的DIP患者可完全康复,但仍有部分患者无法完全康复。我们通过对18F-FP-CIT PET数据进行半定量分析,研究了这些患者纹状体DAT活性是否发生变化。从病历中选取DAT图像视觉上正常的DIP患者。将受试者分为在12个月内部分恢复(PR)或完全恢复(CR)的患者。比较了CR组和PR组各纹状体亚区域的18F-FP-CIT摄取情况。CR组和PR组分别评估了41例和9例患者。两组患者在年龄、性别和帕金森综合征严重程度等临床特征方面具有可比性。通过PET图像的半定量分析,与CR患者相比,PR患者在腹侧纹状体、前壳核和后壳核中的配体摄取相对较低。这一结果表明,DAT成像视觉上正常的患者中持续存在的DIP可能与DAT活性的细微降低有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e7/4905632/5247f694d1c1/pone.0157410.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e7/4905632/5247f694d1c1/pone.0157410.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e7/4905632/5247f694d1c1/pone.0157410.g001.jpg

相似文献

1
Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging.多巴胺转运体成像正常的患者中持续性药物性帕金森综合征
PLoS One. 2016 Jun 13;11(6):e0157410. doi: 10.1371/journal.pone.0157410. eCollection 2016.
2
Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.接触致幻剂后出现的早发型药物诱导性帕金森病提示黑质纹状体多巴胺能功能障碍。
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):169-174. doi: 10.1136/jnnp-2017-315873. Epub 2017 Sep 14.
3
Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.¹²³I-间碘苄胍(MIBG)闪烁显像与多巴胺转运体(DAT)正电子发射断层扫描(PET)联合预测药物诱导帕金森病(DIP)的预后:一项 2 年随访研究。
Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):124-8. doi: 10.1016/j.archger.2012.05.001. Epub 2012 May 26.
4
Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.阿尔茨海默病伴帕金森病和路易体痴呆的 FP-CIT PET 不同模式。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1652-1660. doi: 10.1007/s00259-019-04315-6. Epub 2019 Apr 12.
5
The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism.纯脑白质高信号相关血管性帕金森病中 FP-CIT PET 的模式。
Parkinsonism Relat Disord. 2021 Jan;82:1-6. doi: 10.1016/j.parkreldis.2020.11.002. Epub 2020 Nov 10.
6
Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.11C-PE2I正电子发射断层显像在帕金森病性疾病鉴别诊断中的应用
J Nucl Med. 2015 Feb;56(2):234-42. doi: 10.2967/jnumed.114.148619. Epub 2015 Jan 15.
7
Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT.个体帕金森运动征象与纹状体多巴胺转运体缺失:[I-123]FP-CIT SPECT 研究。
J Neurol. 2019 Apr;266(4):826-834. doi: 10.1007/s00415-019-09202-6. Epub 2019 Jan 28.
8
Dilated Virchow-Robin Space and Dopamine Transporter Imaging in the Striatum of Patients with Parkinsonism.帕金森综合征患者纹状体中扩张的血管周围间隙与多巴胺转运体成像
Can J Neurol Sci. 2015 Jul;42(4):248-54. doi: 10.1017/cjn.2015.43.
9
Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [I]FP-CIT SPECT.未明原因帕金森病和震颤中运动外症状的负担:一项使用 [I]FP-CIT SPECT 的研究。
J Neurol Sci. 2019 Sep 15;404:124-127. doi: 10.1016/j.jns.2019.07.025. Epub 2019 Jul 19.
10
An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.早期帕金森病各亚型多巴胺能神经元丢失差异的氟代脱氧苯丙氨酸-碳-11标记的N-甲基-4-苯基-1,2,3,6-四氢吡啶正电子发射断层扫描比较
Acta Radiol. 2014 Apr;55(3):366-71. doi: 10.1177/0284185113498075. Epub 2013 Aug 13.

引用本文的文献

1
Neuroimaging Techniques in Differentiating Parkinson's Disease from Drug-Induced Parkinsonism: A Comprehensive Review.神经影像学技术在鉴别帕金森病与药物性帕金森综合征中的应用:一项综述
Clin Pract. 2023 Nov 15;13(6):1427-1448. doi: 10.3390/clinpract13060128.
2
How should we be using biomarkers in trials of disease modification in Parkinson's disease?我们应该如何在帕金森病疾病修饰治疗的临床试验中使用生物标志物?
Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265.
3
Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats.

本文引用的文献

1
Neuroleptic-induced Parkinsonism: Clinicopathological study.抗精神病药物所致帕金森综合征:临床病理研究。
Mov Disord. 2016 Mar;31(3):360-5. doi: 10.1002/mds.26467. Epub 2015 Dec 11.
2
Parkinsonism following neuroleptic exposure: A double-hit hypothesis?神经阻滞剂暴露后帕金森病:双重打击假说?
Mov Disord. 2015 May;30(6):780-5. doi: 10.1002/mds.26209. Epub 2015 Mar 18.
3
Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.基于[18F] FP - CIT正电子发射断层扫描的药物性帕金森综合征的临床特征。
纹状体 5-羟色胺转运体功能获得性亢进在左旋多巴治疗的偏侧帕金森病大鼠中的作用。
Brain Res. 2023 Jul 15;1811:148381. doi: 10.1016/j.brainres.2023.148381. Epub 2023 Apr 29.
4
Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism.帕金森病与帕金森综合征鉴别诊断的临床要点
J Clin Neurol. 2022 May;18(3):259-270. doi: 10.3988/jcn.2022.18.3.259.
5
Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.多巴胺转运体显像:一个潜在生物标志物的现状综述。
Int J Mol Sci. 2021 Oct 18;22(20):11234. doi: 10.3390/ijms222011234.
6
Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review.老年患者抗精神病药物所致帕金森综合征的识别与管理:一项叙述性综述
Medicines (Basel). 2021 May 26;8(6):24. doi: 10.3390/medicines8060024.
7
Mirtazapine-associated movement disorders: A literature review.米氮平相关的运动障碍:文献综述
Tzu Chi Med J. 2020 Jul 13;32(4):318-330. doi: 10.4103/tcmj.tcmj_13_20. eCollection 2020 Oct-Dec.
8
Early perfusion and dopamine transporter imaging using F-FP-CIT PET/CT in patients with parkinsonism.帕金森综合征患者早期使用F-FP-CIT PET/CT进行灌注和多巴胺转运体成像
Am J Nucl Med Mol Imaging. 2018 Dec 20;8(6):360-372. eCollection 2018.
9
Clinical features of drug-induced Parkinsonism.药物性帕金森综合征的临床特征。
Neurol Int. 2018 Dec 20;10(4):7877. doi: 10.4081/ni.2018.7877. eCollection 2018 Dec 5.
10
Acute Cervical Dystonia Induced by Clebopride.由氯波必利诱发的急性颈部肌张力障碍。
Case Rep Neurol Med. 2017;2017:2834349. doi: 10.1155/2017/2834349. Epub 2017 Nov 28.
Neurol Sci. 2015 Feb;36(2):269-74. doi: 10.1007/s10072-014-1945-8. Epub 2014 Sep 18.
4
Cerebellum-specific 18F-FDG PET analysis for the detection of subregional glucose metabolism changes in spinocerebellar ataxia.用于检测脊髓小脑共济失调亚区域葡萄糖代谢变化的小脑特异性18F-FDG PET分析
Neuroreport. 2014 Oct 22;25(15):1198-202. doi: 10.1097/WNR.0000000000000247.
5
Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.纹状体多巴胺能神经元缺失预测初发帕金森病患者左旋多巴诱导的运动并发症。
Neurology. 2014 May 6;82(18):1597-604. doi: 10.1212/WNL.0000000000000385. Epub 2014 Apr 9.
6
Neuropathology of parkinsonism in patients with pure Alzheimer's disease.帕金森病在单纯阿尔茨海默病患者中的神经病理学。
J Alzheimers Dis. 2014;39(1):115-20. doi: 10.3233/JAD-131289.
7
Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort.既往抗精神病药物暴露与老年队列帕金森病风险。
Neurology. 2012 Oct 9;79(15):1615-21. doi: 10.1212/WNL.0b013e31826e25ce. Epub 2012 Sep 26.
8
Diagnostic accuracy of 123 I-FP-CIT SPECT in diagnosing drug-induced parkinsonism: a prospective study.123I-FP-CIT SPECT 诊断药物诱导帕金森病的准确性:一项前瞻性研究。
Neurologia. 2013 Jun;28(5):276-82. doi: 10.1016/j.nrl.2012.05.005. Epub 2012 Jul 12.
9
[¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism.[¹²³I]FP-CIT 单光子发射计算机断层扫描在药物诱导的帕金森病中的表现。
Schizophr Res. 2012 Aug;139(1-3):40-5. doi: 10.1016/j.schres.2012.06.003. Epub 2012 Jun 20.
10
Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.¹²³I-间碘苄胍(MIBG)闪烁显像与多巴胺转运体(DAT)正电子发射断层扫描(PET)联合预测药物诱导帕金森病(DIP)的预后:一项 2 年随访研究。
Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):124-8. doi: 10.1016/j.archger.2012.05.001. Epub 2012 May 26.